FDA widens clearance for Siesta's tongue suspension device

01/11/2013 | BeckersASC.com

The FDA has given Siesta Medical expanded clearance for the company's Encore tongue suspension device. The company, which is headquartered in Los Gatos, Calif., can now market the device for multiple suspension loop applications and as a fully adjustable system after implantation in patients with obstructive sleep apnea. "Siesta believes the Encore system is a ... cost effective surgical option for treating OSA patients unable to comply with CPAP use,” said company President and CEO Peter Martin.

View Full Article in:

BeckersASC.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA